Analystreport

Bellerophon Therapeutics (NASDAQ: BLPH) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating.

Bellerophon Therapeutics, Inc.  (BLPH) 
Last bellerophon therapeutics, inc. earnings: 4/6 10:23 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bellerophon.com